Bristol Myers Squibb  is an American pharmaceutical company, headquartered in New York City. Bristol Myers Squibb manufactures prescription pharmaceuticals and biologics in several therapeutic areas, including cancer, HIV/AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis and psychiatric disorders.

Bristol Myers Squibb (BMY) Gains But Lags Market: What You Should Know

Top Analyst Reports for NVIDIA, Bristol-Myers Squibb & ICICI Bank

Bristol Myers (BMY) Loses 10.5% Year-to-Date: What Lies Ahead?

Biotech Stock Roundup: MRTX Falls on Study Failure, LXRX Drug Wins Approval & More

15 Best Healthcare Stocks To Buy Now

3 Top Stocks That Just Went on Sale

Bristol Myers Squibb to Participate in Upcoming Investor Conferences

Bristol Myers' (BMY) Lung Cancer Drug NDA Gets Priority Review

Is Bristol Myers Squibb a Top Dividend Stock?

Bristol Myers Squibb to Hold R&D Day on September 14

Bristol-Myers Squibb Breaks a Key Support Area: What's Next?

Bristol Myers Squibb to Present Late-Breaking Data for Breyanzi (lisocabtagene maraleucel) in Relapsed or Refractory Follicular Lymphoma and Mantle Cell Lymphoma at 2023 International Conference on Malignant Lymphoma

U.S. Food and Drug Administration Accepts for Priority Review Bristol Myers Squibbs Application for Repotrectinib for the Treatment of Patients with Locally Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer

FDA Accepts Iovance's (IOVA) BLA Filing for Melanoma Drug

We Think Bristol-Myers Squibb (NYSE:BMY) Can Stay On Top Of Its Debt

Bristol Myers (BMY) Thrombosis Drug Gets Fast Track Designation

Bristol Myers' CAR T Cell Therapy Shows Deep, Durable Efficacy In Blood Cancer Patients

Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Approval for Opdivo (nivolumab) with Chemotherapy as Neoadjuvant Treatment of Resectable Non-Small Cell Lung Cancer at High Risk of Recurrence in Patients with Tumor Cell PD-L1 Expre...

Top Streaming News